233 related articles for article (PubMed ID: 8153308)
41. Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings.
Faria SL; Menard S; Devic S; Sirois C; Souhami L; Lisbona R; Freeman CR
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1035-8. PubMed ID: 17996383
[TBL] [Abstract][Full Text] [Related]
42. [Contribution of PET using FDG in the diagnosis of lung cancer--first results].
Rubinstein R; Breuer R; Chisin R
Harefuah; 2001 Feb; 140(2):100-3, 191. PubMed ID: 11242909
[TBL] [Abstract][Full Text] [Related]
43. [Accuracy of positron emission tomography with fluorine-18-fluoro-deoxyglucose].
Hellwig D; Gröschel A; Rentz K; Sybrecht GW; Kirsch CM; Ukena D
Pneumologie; 2001 Aug; 55(8):363-6. PubMed ID: 11505287
[TBL] [Abstract][Full Text] [Related]
44. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer.
Weng E; Tran L; Rege S; Safa A; Sadeghi A; Juillard G; Mark R; Santiago S; Brown C; Mandelkern M
Am J Clin Oncol; 2000 Feb; 23(1):47-52. PubMed ID: 10683077
[TBL] [Abstract][Full Text] [Related]
45. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.
Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219
[TBL] [Abstract][Full Text] [Related]
46. Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography.
Hagberg RC; Segall GM; Stark P; Burdon TA; Pompili MF
Eur J Cardiothorac Surg; 1997 Jul; 12(1):92-7. PubMed ID: 9262087
[TBL] [Abstract][Full Text] [Related]
47. Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
Hunter GJ; Choi NC; McLoud TC; Fischman AJ
J Nucl Med; 1993 Sep; 34(9):1571-3. PubMed ID: 8394885
[TBL] [Abstract][Full Text] [Related]
48. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer.
Bury T; Dowlati A; Paulus P; Corhay JL; Hustinx R; Ghaye B; Radermecker M; Rigo P
Eur Respir J; 1997 Nov; 10(11):2529-34. PubMed ID: 9426090
[TBL] [Abstract][Full Text] [Related]
49. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
Newman JS; Francis IR; Kaminski MS; Wahl RL
Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
[TBL] [Abstract][Full Text] [Related]
50. Mediastinal nodes in patients with non-small cell lung cancer: MRI findings with PET/CT and pathologic correlation.
Yeh DW; Lee KS; Han J; Yi CA; Lee HY; Chung MJ; Kim TS
AJR Am J Roentgenol; 2009 Sep; 193(3):813-21. PubMed ID: 19696297
[TBL] [Abstract][Full Text] [Related]
51. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Sundaresan SR; Patterson GA; Cooper JD
AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
[TBL] [Abstract][Full Text] [Related]
52. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging.
Valk PE; Pounds TR; Hopkins DM; Haseman MK; Hofer GA; Greiss HB; Myers RW; Lutrin CL
Ann Thorac Surg; 1995 Dec; 60(6):1573-81; discussion 1581-2. PubMed ID: 8787446
[TBL] [Abstract][Full Text] [Related]
53. Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans.
Zasadny KR; Kison PV; Quint LE; Wahl RL
Radiology; 1996 Dec; 201(3):873-6. PubMed ID: 8939245
[TBL] [Abstract][Full Text] [Related]
54. [Interest of FDG-PET for lung cancer radiotherapy].
Thureau S; Mezzani-Saillard S; Modzelewski R; Edet-Sanson A; Dubray B; Vera P
Cancer Radiother; 2011 Oct; 15(6-7):504-8. PubMed ID: 21880535
[TBL] [Abstract][Full Text] [Related]
55. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion.
Caldwell CB; Mah K; Ung YC; Danjoux CE; Balogh JM; Ganguli SN; Ehrlich LE
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):923-31. PubMed ID: 11704312
[TBL] [Abstract][Full Text] [Related]
56. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
Shreve PD; Grossman HB; Gross MD; Wahl RL
Radiology; 1996 Jun; 199(3):751-6. PubMed ID: 8638000
[TBL] [Abstract][Full Text] [Related]
57. Detection of extrathoracic metastases by positron emission tomography in lung cancer.
Weder W; Schmid RA; Bruchhaus H; Hillinger S; von Schulthess GK; Steinert HC
Ann Thorac Surg; 1998 Sep; 66(3):886-92; discussion 892-3. PubMed ID: 9768946
[TBL] [Abstract][Full Text] [Related]
58. PET scanning said to save money and improve staging of lung cancer.
Oncology (Williston Park); 1995 Nov; 9(11):1200. PubMed ID: 8703689
[No Abstract] [Full Text] [Related]
59. [Detection of unexpected extrathoracic metastases in preoperative staging of non-small-cell bronchial carcinoma (NSCLC) with positron emission tomography (PET)].
Schmid RA; Hillinger S; Bruchhaus H; Steinert HC; von Schulthess GK; Largiadèr F; Weder W
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1264-7. PubMed ID: 9931854
[TBL] [Abstract][Full Text] [Related]
60. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
